BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7969166)

  • 21. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
    Lu Q; Kamps MP
    Oncogene; 1997 Jan; 14(1):75-83. PubMed ID: 9010234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
    Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
    Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
    LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
    Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
    Sykes DB; Kamps MP
    Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
    Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
    Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
    Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
    Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
    Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
    PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role for homodimerization in growth deregulation by E2a fusion proteins.
    Bayly R; LeBrun DP
    Mol Cell Biol; 2000 Aug; 20(16):5789-96. PubMed ID: 10913162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice.
    Feldman BJ; Hampton T; Cleary ML
    Blood; 2000 Sep; 96(5):1906-13. PubMed ID: 10961893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
    Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
    Holmlund T; Lindberg MJ; Grander D; Wallberg AE
    Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA.
    Abramovich C; Shen WF; Pineault N; Imren S; Montpetit B; Largman C; Humphries RK
    J Biol Chem; 2000 Aug; 275(34):26172-7. PubMed ID: 10825160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation.
    Kamps MP
    Curr Top Microbiol Immunol; 1997; 220():25-43. PubMed ID: 9103673
    [No Abstract]   [Full Text] [Related]  

  • 35. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1.
    Knoepfler PS; Kamps MP
    Mol Cell Biol; 1995 Oct; 15(10):5811-9. PubMed ID: 7565734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.
    McWhirter JR; Goulding M; Weiner JA; Chun J; Murre C
    Development; 1997 Sep; 124(17):3221-32. PubMed ID: 9310317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2.
    van Dijk MA; Peltenburg LT; Murre C
    Mech Dev; 1995 Jul; 52(1):99-108. PubMed ID: 7577680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1.
    Smith KS; Chanda SK; Lingbeek M; Ross DT; Botstein D; van Lohuizen M; Cleary ML
    Mol Cell; 2003 Aug; 12(2):393-400. PubMed ID: 14536079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
    Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.